Evidence map›Paper›PMID 24172695›Full record

SynthesisThe review of diabetic studies : RDS2013

Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study.

Giorgina Barbara Piccoli, Roberta Clari, Sara Ghiotto, Natascia Castelluccia, Nicoletta Colombi, Giuseppe Mauro, Elisabetta Tavassoli, Carmela Melluzza, Gianfranca Cabiddu, Giuseppe Gernone and 4 more

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in The review of diabetic studies : RDS, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Risk of Adverse Pregnancy Outcomes in Women with CKD.Journal of the American Society of Nephrology : JASN · 2015
    Observational
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Giorgina Barbara PiccoliSS Nephrology, Department of Clinical and Biological Sciences, University of Torino, Italy.
Roberta Clari
Sara Ghiotto
Natascia Castelluccia
Nicoletta Colombi
Giuseppe Mauro
Elisabetta Tavassoli
Carmela Melluzza
Gianfranca Cabiddu
Giuseppe Gernone
Elena Mongilardi
Martina Ferraresi
Alessandro Rolfo
Tullia Todros
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the last decade, significant improvements have been achieved in maternal-fetal and diabetic care which make pregnancy possible in an increasing number of type 1 diabetic women with end-organ damage. Optimal counseling is important to make the advancements available to the relevant patients and to ensure the safety of mother and child. A systematic review will help to provide a survey of the available methods and to promote optimal counseling.

objectivesTo review the literature on diabetic nephropathy and pregnancy in type 1 diabetes.

methodsMedline, Embase, and the Cochrane Library were scanned in November 2012 (MESH, Emtree, and free terms on pregnancy and diabetic nephropathy). Studies were selected that report on pregnancy outcomes in type 1 diabetic patients with diabetic nephropathy in 1980-2012 (i.e. since the detection of microalbuminuria). Case reports with less than 5 cases and reports on kidney grafts were excluded. Paper selection and data extraction were performed in duplicate and matched for consistency. As the relevant reports were highly heterogeneous, we decided to perform a narrative review, with discussions oriented towards the period of publication.

resultsOf the 1058 references considered, 34 fulfilled the selection criteria, and one was added from reference lists. The number of cases considered in the reports, which generally involved single-center studies, ranged from 5 to 311. The following issues were significant: (i) the evidence is scattered over many reports of differing format and involving small series (only 2 included over 100 patients), (ii) definitions are non-homogeneous, (iii) risks for pregnancy-related adverse events are increased (preterm delivery, caesarean section, perinatal death, and stillbirth) and do not substantially change over time, except for stillbirth (from over 10% to about 5%), (iv) the increase in risks with nephropathy progression needs confirmation in large homogeneous series, (v) the newly reported increase in malformations in diabetic nephropathy underlines the need for further studies.

conclusionsThe heterogeneous evidence from studies on diabetic nephropathy in pregnancy emphasizes the need for further perspective studies on this issue.

Indexed as

Pregnancy in DiabeticsDiabetes Mellitus, Type 1Diabetic NephropathiesFemaleHumansInfant, NewbornMalePregnancyPregnancy ComplicationsPregnancy Outcome

Identifiers

PMID24172695
PMCPMC3932068
OpenAlexW1699566808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.